These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8309596)

  • 1. HIV or zidovudine myopathy?
    Kieburtz K
    Neurology; 1994 Feb; 44(2):361; author reply 362-4. PubMed ID: 8309596
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV or zidovudine myopathy?
    Gherardi R; Chariot P
    Neurology; 1994 Feb; 44(2):361-2; author reply 362-4. PubMed ID: 8309597
    [No Abstract]   [Full Text] [Related]  

  • 3. Zidovudine-related myopathy.
    Daniels DG; McCormack SM; McLean KA; Davies PT; Lane RJ
    Lancet; 1990 Nov; 336(8725):1256. PubMed ID: 1978099
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV or zidovudine myopathy?
    Dalakas M
    Neurology; 1994 Feb; 44(2):360-1; author reply 362-4. PubMed ID: 8309594
    [No Abstract]   [Full Text] [Related]  

  • 5. [Muscular involvement in human immunodeficiency virus infection].
    Laraki R; Lebas J; Baudrimont M; Cabane J; Giral P; Wattiaux MJ; Picard O; Imbert JC
    Ann Med Interne (Paris); 1990; 141(2):187-92. PubMed ID: 2191617
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognosis in AZT myopathy.
    Chalmers AC; Greco CM; Miller RG
    Neurology; 1991 Aug; 41(8):1181-4. PubMed ID: 1714057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIV-1 or zidovudine?
    Till M; MacDonell KB
    Ann Intern Med; 1990 Oct; 113(7):492-4. PubMed ID: 1975486
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of myopathy in a placebo-controlled zidovudine trial.
    Simpson DM; Slasor P; Dafni U; Berger J; Fischl MA; Hall C
    Muscle Nerve; 1997 Mar; 20(3):382-5. PubMed ID: 9052824
    [No Abstract]   [Full Text] [Related]  

  • 9. Muscle disease, HIV and zidovudine: the spectrum of muscle disease in HIV-infected individuals treated with zidovudine.
    Manji H; Harrison MJ; Round JM; Jones DA; Connolly S; Fowler CJ; Williams I; Weller IV
    J Neurol; 1993 Sep; 240(8):479-88. PubMed ID: 8263554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.
    Lane RJ; McLean KA; Moss J; Woodrow DF
    Neuropathol Appl Neurobiol; 1993 Oct; 19(5):406-13. PubMed ID: 8278024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxic drug-induced proximal myopathy in CDC C3 HIV-infection].
    Weisser M
    Praxis (Bern 1994); 1997 Oct; 86(43):1708-10. PubMed ID: 9432697
    [No Abstract]   [Full Text] [Related]  

  • 12. [Muscular involvement in HIV infection].
    Gherardi R; Chariot P; Authier FJ
    Rev Neurol (Paris); 1995 Nov; 151(11):603-7. PubMed ID: 8745623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection.
    Chen SC; Barker SM; Mitchell DH; Stevens SM; O'Neill P; Cunningham AL
    Pathology; 1992 Apr; 24(2):109-11. PubMed ID: 1641255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Muscular complications in HIV infection].
    Authier FJ; Chariot P; Gherardi R
    Arch Anat Cytol Pathol; 1997; 45(2-3):174-8. PubMed ID: 9382610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine-induced lactic acidosis with acute pancreatitis and myopathy: Lethal and rare complications.
    Mahto SK; Gupta PK; Taneja RS; Singh A
    Indian J Pharmacol; 2018; 50(4):212-214. PubMed ID: 30505059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exacerbation of HIV-associated myopathy by zidovudine.
    Berger JR; Shebert R; Gregorios JB
    AIDS; 1991 Feb; 5(2):229-30. PubMed ID: 2031699
    [No Abstract]   [Full Text] [Related]  

  • 17. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
    Mhiri C; Baudrimont M; Bonne G; Geny C; Degoul F; Marsac C; Roullet E; Gherardi R
    Ann Neurol; 1991 Jun; 29(6):606-14. PubMed ID: 1892364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and pathogenesis of myositis in human immunodeficiency virus infection--distinction from azidothymidine-induced myopathy.
    Espinoza LR; Aguilar JL; Espinoza CG; Gresh J; Jara J; Silveira LH; Martinez-Osuna P; Seleznick M
    Rheum Dis Clin North Am; 1991 Feb; 17(1):117-29. PubMed ID: 2041882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zidovudine intolerance.
    Groopman JE
    Rev Infect Dis; 1990; 12 Suppl 5():S500-6. PubMed ID: 2201071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zidovudine therapy and myopathies associated with human immunodeficiency virus infection.
    Chariot P; Ruet E; Gherardi R
    Ann Neurol; 1994 Feb; 35(2):247-8. PubMed ID: 8109910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.